163 related articles for article (PubMed ID: 8401937)
21. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
Panzenbeck MJ; Hintze TH; Kaley G
J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
[TBL] [Abstract][Full Text] [Related]
22. Vasodilating effects of nicorandil and nitroglycerin in anaesthetized open-chest dogs.
Sakanashi M; Noguchi K; Kato T; Sunagawa R; Ito H; Nakasone J
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):439-44. PubMed ID: 2945993
[TBL] [Abstract][Full Text] [Related]
23. Effects of a new antianginal agent, nicorandil, on the cardiovascular system of the miniature pig: with special reference to coronary vasospasm.
Sakai K; Akima M; Shiraki Y; Hoshino E
J Pharmacol Exp Ther; 1983 Oct; 227(1):220-8. PubMed ID: 6225867
[TBL] [Abstract][Full Text] [Related]
24. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114
[TBL] [Abstract][Full Text] [Related]
25. Vagal mediation of the effects of atrial natriuretic factor on blood pressure and arterial baroreflexes in the rabbit.
Volpe M; Cuocolo A; Vecchione F; Mele AF; Condorelli M; Trimarco B
Circ Res; 1987 May; 60(5):747-55. PubMed ID: 2954718
[TBL] [Abstract][Full Text] [Related]
26. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
27. Enhanced subendocardial perfusion distal to a flow-limiting coronary artery stenosis in dogs: comparative effects of nicorandil, a potential new antianginal agent, and nitroglycerin.
Gross GJ; Warltier DC; Hardman HF; Lamping KA
J Cardiovasc Pharmacol; 1985; 7(5):977-82. PubMed ID: 2413311
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term nicorandil application on coronary arteries in conscious dogs.
Huckstorf C; Bassenge E
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S29-33. PubMed ID: 1282173
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs.
Hashimoto K; Ohbayashi Y; Kinoshita M
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1449-54. PubMed ID: 2150492
[TBL] [Abstract][Full Text] [Related]
30. Hypotensive effects and biotransformation of nicorandil, a new antianginal agent, administered to rats by different routes: comparison with nitroglycerin and isosorbide dinitrate.
Sakai K; Akima M; Hinohara Y; Obatake N
J Pharm Pharmacol; 1984 Mar; 36(3):175-81. PubMed ID: 6144752
[TBL] [Abstract][Full Text] [Related]
31. Baroreflex sensitivity alteration following transient hemispheric ischaemia in rats: protective effect of alphamethyldopa and guanfacine.
Saad MA; Elghozi JL; Meyer P
Clin Exp Pharmacol Physiol; 1986 Jul; 13(7):525-34. PubMed ID: 3024888
[TBL] [Abstract][Full Text] [Related]
32. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
Sakai K; Kuromaru O
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420
[TBL] [Abstract][Full Text] [Related]
33. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
Kuromaru O; Sakai K
Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
[TBL] [Abstract][Full Text] [Related]
34. Apparent reduction in baroreflex sensitivity to adenosine in conscious dogs.
Hintze TH; Belloni FL; Harrison JE; Shapiro GC
Am J Physiol; 1985 Sep; 249(3 Pt 2):H554-9. PubMed ID: 3929624
[TBL] [Abstract][Full Text] [Related]
35. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
Auchampach JA; Gross GJ
Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
[TBL] [Abstract][Full Text] [Related]
36. Effects of nicorandil on the conductive coronary artery of the dog.
Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs.
Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H
J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711
[TBL] [Abstract][Full Text] [Related]
38. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
Yamada H; Yoneyama F; Satoh K; Taira N
Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
[TBL] [Abstract][Full Text] [Related]
39. The influence of nicardipine-, nitroglycerin-, and prostaglandin E(1)-induced hypotension on cerebral pressure autoregulation in adult patients during propofol-fentanyl anesthesia.
Endoh H; Honda T; Ohashi S; Hida S; Shibue C; Komura N
Anesth Analg; 2002 Jan; 94(1):169-73, table of contents. PubMed ID: 11772822
[TBL] [Abstract][Full Text] [Related]
40. Effects of nicorandil and other antianginal drugs on myocardial pH in the ischemic dog heart.
Abiko Y; Ichihara K; Sakai K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S85-91. PubMed ID: 2447430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
